JP2006524682A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524682A5
JP2006524682A5 JP2006507414A JP2006507414A JP2006524682A5 JP 2006524682 A5 JP2006524682 A5 JP 2006524682A5 JP 2006507414 A JP2006507414 A JP 2006507414A JP 2006507414 A JP2006507414 A JP 2006507414A JP 2006524682 A5 JP2006524682 A5 JP 2006524682A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound according
compound
following formula
substituted lower
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006507414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524682A (ja
JP4960085B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/008579 external-priority patent/WO2004083235A2/en
Publication of JP2006524682A publication Critical patent/JP2006524682A/ja
Publication of JP2006524682A5 publication Critical patent/JP2006524682A5/ja
Application granted granted Critical
Publication of JP4960085B2 publication Critical patent/JP4960085B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006507414A 2003-03-19 2004-03-19 Ｔｉｅ−２モジュレータと使用方法 Expired - Fee Related JP4960085B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45656503P 2003-03-19 2003-03-19
US60/456,565 2003-03-19
PCT/US2004/008579 WO2004083235A2 (en) 2003-03-19 2004-03-19 Tie-2 modulators and methods of use

Publications (3)

Publication Number Publication Date
JP2006524682A JP2006524682A (ja) 2006-11-02
JP2006524682A5 true JP2006524682A5 (https=) 2007-05-24
JP4960085B2 JP4960085B2 (ja) 2012-06-27

Family

ID=33030100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507414A Expired - Fee Related JP4960085B2 (ja) 2003-03-19 2004-03-19 Ｔｉｅ−２モジュレータと使用方法

Country Status (6)

Country Link
US (1) US8013156B2 (https=)
EP (1) EP1608373A4 (https=)
JP (1) JP4960085B2 (https=)
AU (1) AU2004221812B2 (https=)
CA (1) CA2517291C (https=)
WO (1) WO2004083235A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124625A1 (en) * 2003-10-21 2005-06-09 Salvati Mark E. Piperazine derivatives and their use as modulators of nuclear hormone receptor function
JP2008521900A (ja) 2004-11-30 2008-06-26 アムジエン・インコーポレーテツド キノリン及びキナゾリン類似体並びにがん治療のための医薬としてのその使用
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
AU2013211455B2 (en) * 2005-09-19 2017-12-07 Neuronascent, Inc. Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
EP1937252B1 (en) * 2005-09-19 2017-10-25 Neuronascent, Inc. Compositions for stimulating neurogenesis and inhibiting neuronal degeneration
CN101522644B (zh) * 2006-10-04 2013-04-24 霍夫曼-拉罗奇有限公司 作为cb2受体调节剂的吡嗪-2-羧酰胺衍生物
EP2307456B1 (en) 2008-06-27 2014-10-15 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
NZ779754A (en) 2009-01-16 2023-04-28 Exelixis Inc Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl] oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
US8618111B2 (en) * 2010-01-26 2013-12-31 Boehringer Ingelheim International Gmbh 5-alkynyl-pyrimidines
WO2012061337A1 (en) 2010-11-02 2012-05-10 Exelixis, Inc. Fgfr2 modulators
ES2670550T3 (es) 2013-10-14 2018-05-30 Eisai R&D Management Co., Ltd. Derivados de quinolina selectivamente sustituidos
SG10202103278TA (en) 2013-10-14 2021-04-29 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
AR104882A1 (es) 2015-06-05 2017-08-23 Orion Corp DERIVADOS DE 2-(1-HETEROARILPIPERAZIN-4-IL)METIL-1,4-BENZODIOXANO COMO ANTAGONISTAS DE a2C
EP4568951A1 (en) * 2022-08-08 2025-06-18 Ajax Therapeutics, Inc. Heterocyclic amide and urea compounds as jak2 inhibitors

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI193974A7 (https=) * 1973-07-13 1975-01-14 Merck & Co Inc
DE2428030A1 (de) * 1974-06-11 1976-01-02 Merck Sharp & Dohme Substituierte thiadiazole und verfahren zu ihrer herstellung
EP0096006A3 (de) * 1982-05-28 1984-12-19 Ciba-Geigy Ag 3-(Ureidocyclohexylamino)-propan-1,2-diolderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
IT1191845B (it) * 1986-01-20 1988-03-23 Dompe Farmaceutici Spa Alchiloli derivati farmacologicamente attivi
US4954502A (en) 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
SE8803429D0 (sv) 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
SE9202265D0 (sv) 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives
TW279864B (https=) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
CN1128139C (zh) * 1995-01-11 2003-11-19 三进制药株式会社 新哌嗪衍生物及其制造方法
AR007857A1 (es) * 1996-07-13 1999-11-24 Glaxo Group Ltd Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
JPH1180119A (ja) 1997-07-15 1999-03-26 Sankyo Co Ltd ピペラジン誘導体
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
CA2361179A1 (en) * 1999-03-03 2000-09-08 American Home Products Corporation New diazole derivatives as serotonergic agents
WO2000076984A2 (en) 1999-05-21 2000-12-21 Biovitrum Ab Novel compounds, their use and preparation
SE9901884D0 (sv) * 1999-05-21 1999-05-21 Pharmacia & Upjohn Ab Novel compounds their use and preparation
US6921763B2 (en) * 1999-09-17 2005-07-26 Abbott Laboratories Pyrazolopyrimidines as therapeutic agents
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
EP1301484A2 (en) * 2000-07-20 2003-04-16 Neurogen Corporation Capsaicin receptor ligands
ES2247298T3 (es) 2001-01-23 2006-03-01 Eli Lilly And Company Derivados de piperazina y piperidina como agonistas del receptor de melanocortina.
US20040102455A1 (en) * 2001-01-30 2004-05-27 Burns Christopher John Method of inhibiting kinases
CA2443108A1 (en) * 2001-04-03 2002-10-17 Merck & Co. Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
US7064215B2 (en) 2001-07-03 2006-06-20 Chiron Corporation Indazole benzimidazole compounds
EP1531822B1 (en) * 2002-06-12 2009-08-05 ChemoCentryx Inc 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
US7320979B2 (en) * 2003-04-14 2008-01-22 Abbott Gmbh & Co. Kg. N-[(piperazinyl)hetaryl]arylsulfonamide compounds

Similar Documents

Publication Publication Date Title
JP2006524682A5 (https=)
JP2022506887A5 (https=)
JP2002030084A5 (https=)
JP2006523238A5 (https=)
RU94030499A (ru) Тетрагидроизохинолиновые соединения, их о-ацилированные производные, способ получения, фармацевтическая композиция, способ лечения
RU2011152891A (ru) Диарилгидантоины
JP2010528089A5 (https=)
JP2001526269A5 (https=)
JP2010536887A5 (https=)
CA2407149A1 (en) Melanin-concentrating hormone antagonist
JP2022095882A (ja) 神経膠腫を含むがんを処置するためのエフロルニチンおよびその誘導体および類似体の組成物ならびにそれらの使用方法
JP2007533621A (ja) カンナビノイド受容体調整剤としてのチアゾール誘導体
JP2015051999A (ja) 新しい治療用作用物質
AU2009273259B2 (en) Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
JP2002513793A5 (https=)
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
JP2004535436A5 (https=)
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JP2018507899A5 (https=)
JP2013533253A5 (https=)
JP2011521938A5 (https=)
RU2007108415A (ru) Новое циклическое производное аминобензойной кислоты
RU2005137571A (ru) Новые производные диазабициклононена
JP2003513066A5 (https=)
RU2009136246A (ru) Новые соединения 707 и их применение